EGFR and pancreatic neoplasm: The epidermal growth factor receptor (EGFR) is a suitable target for the early diagnosis of pancreatic cancer with radiolabeled drugs and positron emission tomography (PET), because it plays a key role in regulating cell proliferation and is overexpressed in up to 90% of patients with pancreatic cancer [8,9].